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Abstract
Wehave addressed the capacity of HIV-1 infection to alter the
growth of primary CD4+T cells, but at the clonal level. Single
T cells were expanded in the presence of PHA, IL-2, and small
numbers of accessory dendritic cells. Wereport two new find-
ings. First, T cells from seropositive individuals, even those
with AIDS and markedly reduced CD4+ counts, exhibit a nor-
mal cloning efficiency, and proliferative capacity. This result is
in contrast to two prior reports of a low cloning efficiency in
CD4+ T cells from HIV-1-infected patients. Second, when we
added high doses of exogenous HIV-1 to T cell clones from
control subjects, we observed infection but not cytotoxicity or
loss of CD4+ cells, following addition of virus stocks at days 0,
3, and/or 7 of clonal growth. The same HIV-1 isolates mark-
edly reduced CD4+T cells in bulk mononuclear cultures. When
tested at day 11, HIV-1 mRNAwas expressed in some cells of
exogenously infected clones by in situ hybridization; when
tested at day 18, several clones could transactivate a TAT-sen-
sitive cell line. These findings suggest that the loss of CD4+T
cells in infected individuals is not the inevitable result of the
activation of latent infection, or spread of a productive infec-
tion, during clonal growth.
Introduction
The immune deficiency associated with HIV-l infection is
characterized by a progressive loss of CD4+T lymphocytes (1).
The lethal opportunistic infections of the disease are to a large
extent ascribed to malfunction and depletion of the CD4+
subset, for which HIV- 1 virus has a well-established tropism
(2-4). However, the frequency of CD4+ cells that are produc-
tively infected with HIV-l is much < 1% (5). To explain the
marked depletion of CD4+ lymphocytes, it is possible that
many T cells carry latent virus, which becomes activated upon
antigen stimulation of lymphocytes leading to cell lysis (1, 6).
Indeed, it has been reported that T cells from HIV- 1 infected
patients cannot be cloned efficiently in vitro (7, 8). One expla-
nation would be an early cell lysis of growing T cell clones by
activation of latent virus. Another proposed mechanism for
the loss of CD4+ cells is that a small number of productively
infected cells may kill normal T cells after syncytium forma-
tion (9). Wehave addressed these possible etiologies for the
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loss of CD4' T cells by using a recently described cloning
technique. The method allows early visual detection of devel-
oping CD4' T cell clones in response to a mitogenic stimulus
(10). Surprisingly, we find little evidence for a cytopathic in-
fection in CD4' T cells, from endogenous or exogenous
HIV- 1, when the T cells are grown as clones in the presence of
dendritic cells from seronegative individuals. These findings
indicate that the proliferative potential of most T cells from
HIV- I infected individuals can be substantial.
Methods
Patients. 50 ml heparinized venous blood was obtained on three occa-
sions by venipuncture of 14 HIV- I seropositive male homosexuals
with no record of intravenous drug abuse. All patients had below
normal CD4+/CD8' ratios, and most had low absolute CD4' T cell
counts (see Table I). All patients were on a previous occasion skin
tested for delayed type hypersensitivity responses to a group of anti-
gens: 0.1 ml intermediate strength Candida, Trichophyton (Hollister-
Stier Laboratories, Elkhart, IN) and 5TU PPD(purified protein deriva-
tive'; Connaught Laboratories Ltd., Willowdale, Ontario). Responses
were recorded at 48 h and included > 5 mminduration or erythema
with Candida and Trichophyton and > 10 mminduration with PPD.
Control samples were heparinized venous blood from the concentrated
leukocyte fractions (New York Blood Center) from seronegative
healthy donors.
Cell isolation. Blood mononuclear cells were isolated on Ficoll-
Paque and allowed to form rosettes with neuraminidase-treated sheep
erythrocytes. From the E-rosette positive cell fraction, enriched popu-
lations of CD4' T lymphocytes were obtained by panning to exclude
OKT8 (CD8), 9.3F10 (class MHCII), and OKM1 (CDl lb) positive
cells (10). The purity of the CD4' T cells was determined by double
fluorescence FACScan analysis using a combination of FITC-anti-
CD4 (leu 3) and PE-anti-CD8 (leu 2) (Becton-Dickinson & Co.,
Mountain View, CA). In all cases the percentage of CD4' cells in the
starting populations was > 75%and in most cases 85-90%, while the T
cell clones were almost all CD4' (see Results). Dendritic cells enriched
from buffy coats were used as accessory cells for T cell cloning (10, 11).
Briefly, high density blood mononuclear cells were obtained from Per-
coll gradients (predominantly T cells, B cells, and dendritic cells). T
cells were removed by rosetting with sheep erythrocytes. Cells that did
not form rosettes were separated by a second refloatation in dense
Percoll after 2 d in culture. The low density population contained most
of the dendritic cells, which were further enriched by panning to ex-
clude leukocytes with surface markers for monocytes (Fc receptors), B
cells (CD45R; MAb4G10), NKcells (CDl lb; MAbOKM1).
T cell cloning. Weused a recently described method for cloning of
T cells (10). 1,000 irradiated (3,000 rad) dendritic cells (- 50% pure)
in 50 ,ul were added as feeders or accessory cells. This dose of dendritic
cells corresponds roughly to their incidence in 105 bulk mononuclear
cells, which is the standard accessory population for optimal cloning
efficiency. CD4+ T lymphocytes (50 ul) were plated in 96 well round-
bottomed microplates (Linbro, Flow Laboratories, VA) at an average
frequency of I T cell/well. The cultures were supplemented with 50 M1
growth medium which was PHA(20 ,g/ml; Difco Laboratories, De-
1. Abbreviation used in this paper: PPD, purified protein derivative.
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Table I. Clinical Parameters of Examined HIV-I Infected Individuals
Patient CD4/CD8 count Skin testing
No. Diagnosis Drug therapy cell/mm3* Candida/Trichophyton/PPD
1 Asymptomatic None 310/890 All negative
2 Asymptomatic None 380/620 10 mmCandida
6 mmTrichophyton
3 Asymptomatic AZT disulfiram 240/500 All negative
4 Asymptomatic disulfiram 550/1630 All negative
5 Asymptomatic None 510/440 All negative
6 Asymptomatic AZT DTC§ 370/590 All negative
7 Asymptomatic None 530/840 11 mmCandida
8 ARC AZT 200/620 All negative
9 ARC Ampligen 280/580 8 mmCandida
10 ARC AZT 400/1830 All negative
11 ARC None 320/1860 All negative
12 ARC AZT 610/1880 5 mmCandida
13 AIDS/KS DTC 220/920 All negative
14 AIDS/KS AZT 420/990 All negative
* The normal range of CD4and CD8counts are 550-1,100 and 300-600 cells/mm3. AZT, azidothymidine. § DTC, diethyldithiocarbamate.
troit, MI) plus 300 U/ml rIL-2 (DuPont, Wilmington, DE), or PHA-
conditioned medium (10, 12). The latter was made in our laboratory
by stimulation of blood mononuclear cells (2 X 106 cells/ml) with 20
gg/ml PHAfor 48 h in RPMI 1640 medium supplemented with 2 mM
glutamine, antibiotics, 20 uM 2-mercaptoethanol, and 10% human
serum (10). The culture plates were incubated at 370C in 5%CO2in a
humidified incubator and clones were enumerated by microscopy at
days 7, 10, and 14 and the cloning efficiencies were calculated based on
120-160 observations. A maximum of 67% positive wells is predicted
by the Poisson distribution when plating is performed at 1 cell/well.
Thus, the cloning efficiency was calculated as 3/2 of the observed
percentage of wells with clones. Further expansion of clones beyond 14
d was obtained by transferring the clones from the microwells to 24
well plates (16 mm)precoated with an irradiated (3,000 rad) layer of
adherent cells in a total volume of 1.5 ml in 30% (vol/vol) conditioned
medium supplemented with 20% purified human IL-2 (Electro-Nu-
cleonics, Inc., Fairfield, NJ).
Endogenous HIV-I production from CD4positive patient T cells.
The CD4' T cells from the erythrocyte rosette fraction (1 X 106 cells/
ml in 6 ml) were cocultured with PHAstimulated lymphoblasts (0.5
X 106/ml) in 25 cm2 tissue culture flasks (Costar, Cambridge, MA) and
were supplemented with IL-2 (600 U/ml; New England Nuclear Re-
search Products, Boston, MA). Culture supernatants were collected
over 3-5-d intervals, concentrated with polyethylene glycol 8000 and
analyzed for virus production by p24 antigen ELISA (New England
Nuclear). Productive infection in T cell clones was measured similarly
by p24 ELISA from 100 Ml of the clone supernatants.
Infection of bulk cultures and T cells clones with exogenous HTLV-
IIb. For in vitro propagation of virus in bulk cultures of blood mono-
nuclear cells, the system described by McDougal et al. was used (6).
Ficoll-Paque separated mononuclear cells from seronegative donors
were stimulated with 20 ug/ml PHA for 3 d at 2 X 106 cells/ml in
medium. The PHA-stimulated cells were harvested by centrifugation
and resuspended to 2 X 106 cells/ml in medium without PHAbut
supplemented with 300 U/ml rIL-2. The lymphoblast-rich cell cultures
were inoculated with an HIV-I supernatant containing HTLV-IIIb
virus (10,000 cpm reverse transcriptase/ml) or with a fresh patient
isolate that had been expanded on PHAstimulated T cell blasts. Every
3 d the culture medium was exchanged with rIL-2 supplemented fresh
medium, and the cultures were maintained at I to 2 X 106 cells/ml. At
each time point, viable cell counts were determined by trypan blue
exclusion, and expression of CD3+, CD4+, and CD8+ antigens was
measured by flow cytometry. Cytocentrifuged cell preparations for in
situ hybridization (below) were also made. For propagation of virus in
CD4+ T cell clones, the HTLV-IIIb isolate was in six different experi-
ments added (25 gl) to the cloning wells at days 0, 3, or 7 (1,400, 700,
or 70 cpm/well). In two additional experiments a patient HIV- I isolate
was added to the cloning wells at day 3 (700 cpm/well). In control
plates, 25 ,l of supernatant from an uninfected CEM-4 cell line or
from uninfected T cell cultures were used.
In situ hybridization for HIV-J mRNA. For in situ hybridization
studies glass slides were coated for 3 h in Denhardt's medium ( 13) at
65°C, dipped briefly in distilled water, transferred to ethanol-acetic
acid (3:1 vol/vol) for 20 min and air dried. After making the cytocen-
trifuge preparations (3 X 104 cells per slide; cytocentrifuge; Shandon
Southern Instruments, Inc., Sewickley, PA) the slides were air dried
and immediately fixed for 20 min at room temperature in freshly
prepared 4% paraformaldehyde in phosphate-buffered saline (PBS)
with 5 mMMgCl. The slides were rinsed for 3 min in 3X PBS, twice for
I min in I X PBS, and dehydrated in ethanol. After drying the slides
were stored at -20°C until use.
The plasmid pBH10, containing a 9-kb insert with the complete
cDNAof HTLV-III (14, 15), was digested with BamHI and Hind III.
The 0.6 kB Hind III fragment, containing a part of the gag gene was
isolated and random primer labeled as described (16) with a mixture of
3H-nucleotides ([3H]dTTP, [3H]dCTP, [3H]dATP; NewEngland Nu-
clear). The cytospin preparations were rehydrated, treated for 20 min
at room temperature with 0.2 NHCI, washed in 2X SSCfor 20 min at
50°C, followed by an acetylation step for 10 min in 0.1 M3-ethanol-
amine and 0.25% acetic anhydride. The slides were washed for 5 min in
PBS. On each slide 20 Ml of hybridization mixture was loaded, which
contained 4 X 105 cpm of 3H-labeled cDNA probe, 50% deionized
formamide, IX Denhardt's solution, 2% Dextran sulphate, 0.3 M
NaCl, 80 ug/ml salmon sperm DNA, 5 mg/ml yeast tRNA, and 10
mMTris-HCI, pH 7.5. Siliconized coverslips were placed on top of the
cells and sealed with rubber cement. The slides were incubated at 42°C
overnight and then washed at 37°C as follows: 30 min in 4X SSC, 2 X 1
h in 4X SSC, 2 X 1 h in 2X SSC, and at least 30 min in lX SSC. The
washed slides were dehydrated in ethanol and dipped in NTB2 emul-
sion (Eastman Kodak, Rochester, NY) diluted 1: 1 with double distilled
water. After 2-4 d exposure, the slides were developed (D19; Kodak)
for 5 min, rinsed for 1 min in tap water, and fixed (Rapid Fixer;
Kodak) for 5 min. The slides were washed with tap water for 30 min
and stained with hematoxylin. Cells were considered positive for
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HTLV-IIIb RNAexpression when there were more grains than the
mean + 3 SD of the grains in control cell preparations. The back-
ground grains per cell in uninfected control T cell preparations was
1.7±1.2.
Transactivation of LTR-CAT transfected H938 cells. The CD4'
H938 cell line described by Felber et al. was used (17). This cell line
carries an HIV-l 5' LTR-CAT construct, which is transactivated upon
contact with a small number of infected cells (17). Briefly, the total
content (150 ul) of the cloning wells (with or without clones) were
transferred at day 18 to cultures with 2.5 X 105 H938 cells in 1 ml
growth medium and cultured for 48 h before analysis of CATenzyme
activity. A positive CATassay reflects transactivation of the CATgene
by the TAT product from cells infected with HIV- I (17).
Statistical analysis. Differences in cloning efficiencies between
groups were tested with an analysis of variance (one-way). P < 0.05
were considered significant.
Results
Patient sample. 14 seropositive patients were included in this
study (Table I). Half had symptoms, and two of these had
AIDS and Kaposi's sarcoma. Most patients had a decreased
absolute number of CD4' T cells, and the CD4/CD8 ratio was
< 1. Only four patients exhibited delayed type hypersensitivity
upon skin testing with Candida, Trichophyton, and PPDanti-
gens.
Cloning of T cells from HIV-I-infected patients. In the
cloning assay we used dendritic cells from a seronegative
donor as accessory cells for the prolonged growth of single T
cells from patients or from control subjects. Because only
1,000 dendritic cells were needed to induce a maximal yield of
ii
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clones (10), it was possible to identify the growing clones as
early as day 5 of culture. Typical clones from two patients and
one control at day 7 are shown in Fig. 1. At day 14, the clones
had increased further in size, so that the cultures contained a
cluster of cells surrounded by a large sheath of lymphoblasts as
described (10). In all cases, the sizes of the patient clones and
cell viability (trypan blue) were comparable to the controls.
There was no evidence of syncytium formation (Fig. 1). No
clones were detected in wells that only contained T cells or
dendritic cells.
The cloning efficiencies of patient and control T cells were
measured at days 7, 10, and 14 by microscopic examination.
At each time point, the yield of clones was similar (Table II) in
patient groups and controls (P = 0.23, F = 1.62, analysis of
variance). By day 14, the cell yield was 20,000-40,000 cells,
corresponding to a minimum of 15 rounds of clonal expan-
sion. The reproducibility of the cloning efficiency was tested
on two occasions for one patient (66 and 75%) and one control
(64 and 69%).
Wealso examined the cloning efficiency of single T cells
expanded in exogenous rIL-2 rather than bulk T cell condi-
tioned medium (Table III). Wewere concerned that the latter,
because of its high content of IFN-y (> 280 U/ml), might
interfere with the activation of a latent HIV-l infection. How-
ever, the cloning efficiency was comparable with either recom-
binant or bulk growth factors. Weconclude that CD4' T cells
from HIV- 1 seropositive donors can undergo prolonged
growth with a cloning efficiency that is comparable to controls.
.'f
Figure 1. Typical clones from one control subject, two patients, and one control clone cultured with HIV- I virus. The clones were photo-
graphed at day 7 and day 14 with an inverted microscope and shown at a final magnification of 150. The clones consists of a tight cluster of
cells surrounded by a sheath of enlarged lymphoblasts (a; Control at day 7. b; Patient 3 at day 7. c; Patient 3 at day 14. d; Patient 9 at day 7. e
and f; Control clone grown in the presence of HIV-1 virus at day 7 and 14, respectively).
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Table II. Cloning Efficiencies of CD4' Lymphocytes from 14




Donor Clinical status ratio d7/dlO/dl4
Controlt 2.2 63/63/64
Control 1.8 39/45/48
Controlt - 2.4 66/66/69
Control 3.8 79/90/91
Control - 1.6 45/48/54
Group median: 2.0 63/63/64
Patient 1 Asymptomatic 0.4 77/81/83
Patient 2 Asymptomatic 0.6 45/62/67
Patient 3 Asymptomatic 0.5 85/86/86
Patient 4 Asymptomatic 0.3 69/72/69
Patient 5 Asymptomatic 1.2 69/82/82
Patient 6 Asymptomatic 0.6 64/66/69
Patient 7 Asymptomatic 0.6 63/75/75
Group median: 0.6 69/75/75
Patient 8 ARC 0.3 69/72/72
Patient 9 ARC 0.5 46/59/66
Patient 10 ARC 0.2 50/54/59
Patient 11 ARC 0.2 42/46/48
Patient 12 ARC 0.3 86/88/88
Group median: 0.3 50/59/66
Patient 13 AIDS/KS 0.2 61/72/75
Patient 14 AIDS/KS 0.4 43/51/58
Group median: 0.3 53/62/67
* Percent cloning efficiency examined at days 7, 10, 14.
t control subject and patient 9 were tested on two occasions in
the cloning assay. The cloning efficiency (%) of patient 9 was in the
second experiment 69/75/75. A one-way analysis of variance was
used for statistical analysis of cloning efficiencies between patient
and control groups at day 14 (P = 0.23).
Lack of production of HIV-J in clonal cultures. Endoge-
nous production of virus was evaluated with an ELISA assay
for the HIV- 1 p24 antigen. 1 5 cultures from patients 2, 8, and
12 were negative after 2 wk of growth. In contrast, bulk cell
Table III. Comparable Cloning Efficiencies of Patient CD4'
Lymphocytes in the Presence of Bulk Conditioned Medium
or rIL-2 and PHA
Donor Day 7 Day 10 Day 14
Conditioned medium
Patient 8 58 77 86
Patient 12 86 88 88
Lectin and rIL-2
Patient 8 54 74 74
Patient 12 64 85 94
Single CD4' T cells from two patients with low CD4' T cell counts
were cloned using as a source of growth factor either bulk leukocyte
conditioned medium (which contained > 280 U/ml of INF-y) or
rIL-2 with PHA. The efficiency of cloning was measured at days 7,






Figure 2. Double fluorescence labeling for CD8 (PE-leu2) and CD4
(FITC-leu3) antigens. Staining was performed directly in the cloning
wells at day 13. Note that the expression of CD4 is comparable in
the patient and the control clones.
cultures from patients 2 and 8 with lymphoblasts and IL-2
produced p24 (data not shown).
Normal expression of CD4 antigen on patient clones. Ex-
pression of CD4 and CD8 was monitored by two-color flow
cytometry in 4 control clones and in 12 clones from patients.
PE-anti-CD8 and FITC-anti-CD4 were added directly to the
cloning wells at 11 d of growth. 11/12 patient clones were
CD4'CD8-, and the level of CD4was comparable to control
clones (Fig. 2).
Cloning of normal T cells in the presence of exogenous
HIV-1. A high dose of a standard T lymphotropic virus isolate,
HTLV-IIIb, was added to single cell cloning wells of control
donors at day 0 and/or day 3. The highest doses of virus in
terms of RTase units (1,400 or 700 U/1 50 gl) in a round-bot-
tomed well with one T cell was roughly comparable to the dose
used to establish a productive infection in bulk mononuclear
cells (10,000 U/ml). Remarkably, cloning efficiency was not
decreased (Table IV), and there was no evidence of cytotoxic-
ity (trypan blue stain) or syncytium formation (Fig. 1, e andf).
In two other experiments, virus was added at days 0 and 7
with the same results, i.e., no observed cytopathic effects.
When the same virus stock was added to bulk blood mononu-
clear cell cultures, the virus caused the expected loss of CD4'
Table IV. Cloning Efficiencies of CD41 Lymphocytes in the
Presence of Exogenous HIV-1
Day O Day 3 Day 3
Donor None/700 cpm* None/70 cpm None/700 cpm
Conditioned medium
Exp. 1 85/69 85/96 96/96
Exp. 2 88/80 96/96 101/96
Lectin and rIL-2
Exp. 1 53/53 69/61 61/53
Exp. 2 72/80 72/69 88/80
* CD41 T cells from 2 healthy control subjects were cloned in either
PHA-conditioned medium, or PHAand rIL-2. At different time
points HIV- I virus (700 or 70 cpm of reverse transcriptase activity,
HTLVIIIb isolate) was added to the cloning wells.
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Table V. In Situ Hybridization of HIV-i mRNAin Cell Cultures Infected with Exogenous HIV-1
Days after infection with HIV-l virus
0 4 7 11 14 18
(A) Bulk mononuclear cells
%CD4' Tcells ND 54 28 7 5 2
%positive cells by in situ hybridization 0 ND 5 9 0 0
(B) CD4' T cell clones
Clone number 1 2 3 4 5 6 7 8
%HIV-1 positivecells 0 7 0 0 59 0 1 0
(A) In bulk mononuclear cell cultures inoculated with HIV-I virus, the percentage of CD4' T cells was followed by immunolabeling (FITC-leu
3 and PE-leu 2). Cytocentrifuged cell preparations from each time point were used for in situ hybridization for HIV-1 mRNA. (B) Eight clones
were grown in the presence of HIV- I virus. 11 d after initiation of the experiments cytocentrifuge preparations were made for in situ hybridiza-
tion for HIV- I mRNA. Four control clones (not shown) cultured without HIV- I were negative.
cells that has been reported by others (6, 18). A second HIV-1
isolate, derived from a patient and propagated in short-term
culture with PHA-stimulated human T lymphoblasts, was also
added to cloning wells at day 3. In two experiments, the clon-
ing efficiencies at day 14 were again not affected by exogenous
HIV-l virus (78 and 84%), even though this isolate also elimi-
nated most CD4 cells from 11 to 14 d PHA-stimulated bulk
mononuclear cells.
Since exogenous HIV- 1 was lytic for bulk mononuclear
cells, but not T cells growing as clones with accessory dendritic
cells, we examined the clones for productive infection. Because
of the high dose of exogenous HIV, p24 assays gave a high
background even in wells without clones. Therefore, we evalu-
ated the clones by in situ hybridization with a 3H-cDNA probe
for HIV- I gag mRNA. Positive cells were seen in bulk mono-
nuclear cells infected with HIV-1 (Table V). Of eight clones
examined at day 11 of growth, three contained T cells with
HIV-l mRNA(Table V). Fig. 3 shows the clarity of the in situ
approach on bulk mononuclear cells (Fig. 3a), CEMT cell
cultures (Fig. 3 b), and a T cell clone (Fig. 3 d) all infected with
the same HTLV-IIIb isolate. The grain counts were similar in
the clonal and bulk T cell cultures, suggesting that the levels of
gag mRNAwere similar. At no time did we observe hybridiza-
tion signals on uninfected cells (Fig. 3 c).
To detect the presence of an active tat gene product in the
exogenously infected clones, we cocultured the clones with the
CD4+ H938 cell line tranfected with LTR-CAT. Three of
seven clones tested at day 18 induced responses by the CAT
assay. Fig. 4 shows transactivation by two clones (lanes 1 and
3) of four shown. In wells without clones, but with exogenous
HIV- 1, little or no CATenzyme activity was detected (lanes 6
and 7). Therefore, clonal expansion of T cells occurs in our
culture system in the presence of some HIV-l-infected lym-
phocytes.
Figure 3. In situ hybridization to detect
HIV-I mRNA.A 0.6 kB 3H-cDNA probe
was applied to (a) HIV- I infected PBMC
cell cultures at d. I 1. (b) HIV- I infected
CEMcell lines. (c) uninfected control T
cell clone. (d) T cell clone infected at day 0
with HIV-I.
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Figure 4. Transactivation of the LTR-CAT construct in H938 cell
lines. Lanes 1-4; wells with T cell clones grown in the presence of
9 Y Y V - - - HIV-1 (HTLVIIIb). Two of the clones (lanes I and 3) transactivated
theH938 cells. Lane 5; H938 cell alone, lanes 6 and 7; wells in
which a T cell clone did not grow but HIV- 1 (700 RTase cpm/well)
1 2 3 4 5 6 7 wasaddedtothewell.
Discussion
The malfunction and loss of CD4' T cells is a critical conse-
quence of HIV-l infection and likely predisposes to lethal op-
portunistic infections. Our experiments consider some of the
possible mechanisms for the loss of CD4' T cells, but in con-
trast to many prior studies we have emphasized freshly isolated
CD41 cells and clonal assays.
Although very few blood cells are productively infected
with HIV-1 (5), there is evidence that the infection is much
more extensive. First, it has been reported that single CD41 T
cells from patients can only be cloned with a very low effi-
ciency (7, 8). This suggests that many T cells are carrying latent
virus, which is activated upon clonal expansion, or that single
T cells carry a strong inhibitor of cell growth. Second, in stud-
ies with cell lines, a few infected cells transmit by syncytium
formation the infection to uninfected cells (9). Our observa-
tions, however, provide a very different picture of the growth
potential of CD41 T cells even when taken from patients with
extensive loss of CD41 T cells.
When single CD4' T cells from HIV-infected individuals
were stimulated in culture with PHA, growth factors, and nor-
mal accessory dendritic cells, the lymphocytes grew contin-
uously producing large clones with the same efficiency as T
cells from controls (Table II). There was no evidence for pro-
duction of HIV p24, for a loss of CD4 antigen that can occur
upon HIV infection (3, 18-20), or for cytotoxicity and syncy-
tium formation. Therefore, the idea that many T cells are
carrying latent HIV, which can be activated upon clonal ex-
pansion, does not seem to be the case even in a group of
patients with low CD4counts and frank ARC/AIDS (Table I).
Further studies, as with DNAamplification, will be required to
establish if a significant fraction of the patient's T cells are
maintaining virus in a latent state during clonal expansion, but
the biology is clear. T cells from these patients can undergo
prolonged growth.
Other studies of the cloning capacity of T lymphocytes
from HIV infected patients have reported a decreased cloning
efficiency with different experimental protocols. In one study,
single T cells were cloned in the presence of rIL-2, PHAand
bulk mononuclear cells as accessory cells. The cloning effi-
ciency was decreased (range 15-36%) for both CD41 and
CD8' subsets (7). A second study (8) found more than a five
fold decrease in the cloning efficiency, again of both CD8' and
CD4' cells, using a limiting dilution approach. Both studies
used a high number of bulk mononuclear cells as accessory
cells, and not dendritic cells. It is conceivable that the use of
enriched dendritic cells improves clonal growth. In both prior
reports, the cloning efficiency of patient CD8' cells was also
found decreased. Someof the patients in these studies differed
from the patients in our study by having CD4' T cell counts
< 100 per mm3. However, the median cloning efficiency of
CD4' T cells from these patients was not different from that of
patients with CD4' T cell counts > 100/mm3. It is possible
that the coculture with dendritic cells provides a protective
environment that may not be present when bulk mononuclear
cells are used as accessory cells. This possibility is currently
under investigation. Of some interest as well will be to test if
dendritic cells from patients will support the cloning of normal
or patient T cells. Such experiments, however, will require
improved methods for enriching dendritic cells from small
volumes of patient blood.
It was clear that exogenous HIV-1 dramatically reduced
CD4' cell counts when bulk mononuclear cells were being
stimulated with PHA(Table V) as was the experience of others
(1, 4, 6, 21). Yet we did not observe this to be the case in our
primary clones using a standard HTLVIIIb virus stock, and we
had similar results with a fresh patient virus isolate. Exogenous
virus (HTLVIIIb) clearly infected some of the cells in the T cell
clones, and the levels of gag mRNAby in situ hybridization
were comparable to bulk mononuclear cells (Figs. 3 and 4).
Nonetheless the clones remained robust, and syncytia were
never apparent. It is possible that the few cells that became
infected in our cloning cultures died rather than propagated
the infection. Alternatively, a persistent but noncytopathic in-
fection could have been established as has been noted in one
study of bulk cultures (18). Wewill examine these possibilities
in the future using the polymerase chain reaction to detect
HIV-l DNA.
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